Comparison of Risk Prediction Models to Estimate Opioid-Induced Respiratory Depression, Oversedation, and Overdose in Patients with Cancer

被引:0
作者
Tung, Norint P. [1 ]
Kaleo, Parker K. [1 ]
Roeland, Eric J. [2 ]
Ma, Joseph D. [1 ]
机构
[1] Univ Calif UC San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA
关键词
Opioid; cancer pain; respiratory depression; oversedation; prediction model; RETROSPECTIVE ANALYSIS; SCREENING METHODS; VETERANS; INDEX; VALIDATION; TOOL;
D O I
10.1080/15360288.2025.2481186
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Numerous opioid-induced respiratory depression (OIRD), oversedation, and overdose prediction models exist to quantify a probability or estimate risk severity for a future event. The primary aim was to determine OIRD, oversedation, and overdose risk severity (i.e., low, moderate, and high) and agreement of risk severity between three previously published prediction models. This single-center, retrospective analysis evaluated 134 patients with cancer. Sixty-five (49%) patients were Caucasian. Forty-three (32%) patients were diagnosed with gastrointestinal cancer. Predictive factors from prediction models were concurrent sedating medication (n = 119, 89%), female sex (n = 85, 63%), a mental health diagnosis (n = 68, 51%), and antidepressant use (n = 55, 41%). For most patients, risk severity varied between moderate to high risk. Risk class severity was significantly different between prediction models (p <= 0.05). Frequencies of risk severity agreement between all three prediction models, between two prediction models, and no agreement was 16% (n = 22), 69% (n = 93), and 14% (n = 19), respectively. Additional research is needed to evaluate model calibration to increase OIRD, oversedation, and overdose prediction model validity and generalizability for future clinical implementation.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Postoperative opioid administration characteristics associated with opioid-induced respiratory depression: Results from the PRODIGY trial
    Urman, Richard D.
    Khanna, Ashish K.
    Bergese, Sergio D.
    Buhre, Wolfgang
    Wittmann, Maria
    Le Guen, Morgan
    Overdyk, Frank J.
    Di Piazza, Fabio
    Saager, Leif
    JOURNAL OF CLINICAL ANESTHESIA, 2021, 70
  • [22] Opioid-induced respiratory depression is associated with increased tidal volume variability
    Bouillon, T
    Bruhn, J
    Roepcke, H
    Hoeft, A
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2003, 20 (02) : 127 - 133
  • [23] Preventing Postoperative Opioid-Induced Respiratory Depression Through Implementation of an Enhanced Monitoring Program
    Kozub, Elizabeth
    Uttermark, Anne
    Skoog, Richard
    Dickey, William
    JOURNAL FOR HEALTHCARE QUALITY, 2022, 44 (01) : E7 - E14
  • [24] Knowledge of opioid-induced respiratory depression among Chinese health care professionals: A cross-sectional study
    Li, Xin
    Li, Na
    Lu, Yuhan
    Ma, Xiaoxiao
    Yang, Hong
    Sun, Hong
    Chen, Fan
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2022, 9 (01) : 55 - 60
  • [25] Opioid-induced Neurotoxicity in Patients with Cancer Pain
    Mercadante, Sebastiano
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (10) : 1367 - 1377
  • [26] Opioid-induced Neurotoxicity in Patients with Cancer Pain
    Sebastiano Mercadante
    Current Treatment Options in Oncology, 2023, 24 : 1367 - 1377
  • [27] The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
    Lakkad, Mrinmayee
    Martin, Bradley
    Li, Chenghui
    Harrington, Sarah
    Dayer, Lindsey
    Painter, Jacob T.
    JOURNAL OF CANCER SURVIVORSHIP, 2024, 18 (03) : 917 - 927
  • [28] Risk factors for severe opioid-induced respiratory depression in hospitalized adults: A case-control study
    Boitor, Madalina
    Ballard, Ariane
    Emed, Jessica
    Le May, Sylvie
    Gelinas, Celine
    CANADIAN JOURNAL OF PAIN-REVUE CANADIENNE DE LA DOULEUR, 2020, 4 (01): : 103 - 110
  • [29] Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone
    Omoto, Takashi
    Asaka, Junichi
    Nihei, Satoru
    Kudo, Kenzo
    SUPPORTIVE CARE IN CANCER, 2023, 31 (04)
  • [30] Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone
    Takashi Omoto
    Junichi Asaka
    Satoru Nihei
    Kenzo Kudo
    Supportive Care in Cancer, 2023, 31